Price T Rowe Associates Inc Cytokinetics Inc Transaction History

Price T Rowe Associates Inc

$869 Billion
Q3 2024

A detailed history of Price T Rowe Associates Inc transactions in Cytokinetics Inc stock. As of the latest transaction made, Price T Rowe Associates Inc holds 3,164,945 shares of CYTK stock, worth $154 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

3,164,945

Previous 2,358,343 34.2%

Holding current value

$154 Million

Previous $128 Million 30.78%

% of portfolio

0.02%

Previous 0.02%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$51.22 - $60.16 $41.3 Million - $48.5 Million	806,602 Added 34.2%	3,164,945 $167 Million
Q2 2024 Aug 14, 2024	SELL	$47.86 - $75.05 $27.4 Million - $43 Million	-572,605 Reduced 19.54%	2,358,343 $128 Million
Q1 2024 May 15, 2024	SELL	$63.75 - $108.06 $20 Million - $33.9 Million	-313,302 Reduced 9.66%	2,930,948 $205 Million
Q4 2023 Feb 14, 2024	BUY	$26.88 - $83.49 $60 Million - $186 Million	2,232,623 Added 220.7%	3,244,250 $271 Million
Q3 2023 Nov 14, 2023	SELL	$29.46 - $36.61 $2.17 Million - $2.7 Million	-73,686 Reduced 6.79%	1,011,627 $29.8 Million
Q2 2023 Aug 14, 2023	SELL	$32.62 - $40.75 $2.83 Million - $3.53 Million	-86,716 Reduced 7.4%	1,085,313 $35.4 Million
Q1 2023 May 15, 2023	BUY	$33.36 - $45.71 $2.14 Million - $2.93 Million	64,168 Added 5.79%	1,172,029 $41.2 Million
Q4 2022 Feb 14, 2023	BUY	$35.77 - $51.11 $515,588 - $736,699	14,414 Added 1.32%	1,107,861 $50.8 Million
Q3 2022 Nov 14, 2022	BUY	$38.54 - $54.52 $23 Million - $32.5 Million	595,708 Added 119.68%	1,093,447 $53 Million
Q2 2022 Aug 15, 2022	BUY	$33.93 - $48.92 $1.2 Million - $1.72 Million	35,256 Added 7.62%	497,739 $19.6 Million
Q1 2022 May 16, 2022	BUY	$29.74 - $46.0 $9.31 Million - $14.4 Million	313,044 Added 209.48%	462,483 $17 Million
Q4 2021 Feb 14, 2022	BUY	$34.35 - $46.38 $4.12 Million - $5.56 Million	119,982 Added 407.31%	149,439 $6.81 Million
Q3 2021 Nov 15, 2021	BUY	$18.54 - $35.74 $18,836 - $36,311	1,016 Added 3.57%	29,457 $1.05 Million
Q2 2021 Aug 16, 2021	BUY	$19.79 - $26.99 $24,955 - $34,034	1,261 Added 4.64%	28,441 $563,000
Q1 2021 May 17, 2021	BUY	$18.57 - $25.68 $67,854 - $93,834	3,654 Added 15.53%	27,180 $632,000
Q4 2020 Feb 16, 2021	BUY	$15.26 - $28.61 $359,006 - $673,078	23,526 New	23,526 $489,000

Others Institutions Holding CYTK

# of Institutions

409

Shares Held

125M

Call Options Held

4.6M

Put Options Held

2.43M

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.57B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Cytokinetics Inc Transaction History